Top Markets
Coin of the day
Exscientia plc Exscientia plc

Exscientia plc

EXAI
Rank in Stocks #99999
Exscientia plc, an artificial intelligence-driven pharmatech company, engages... Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Share Price
$4.84
Market Cap
$633.18M
Change (1 day)
3.20%
Change (1 year)
0.00%
Country
GB
Trade Exscientia plc (EXAI)

Category

Operating Margin for Exscientia plc (EXAI)
Operating Margin as of April 2026 TTM: -876.56%
According to Exscientia plc latest financial reports and stock price the company's current Operating Margin (TTM) is -876.56%. At the end of 2022 the company had an Operating Margin of -533.13%.
Operating Margin history for Exscientia plc from 2019 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -876.56% 0.00%
2023 -876.56% 64.42%
2022 -533.13% 161.97%
2021 -203.51% -15.12%
2020 -239.75% 194.97%
2019 -81.28% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
41.30% -100.05%
DK
35.45% -100.04%
US
24.95% -100.03%
US
25.32% -100.03%
BE
25.72% -100.03%
AU
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.